NUVB — Nuvation Bio Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2020-08-26.
Performance
Technicals
Others in Healthcare
Measured signals that fired on NUVB
| date | signal | measured base rate |
|---|---|---|
| 2026-08-19 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-08-14 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
| 2026-07-21 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-07-21 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-06-22 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-06-04 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-19 | Hattersley Gary CHIEF SCIENTIFIC OFFICER | Open-market sale 10b5-1 plan | 100.0K | 7.09 | 709.2K |
| 2026-08-19 | Hattersley Gary CHIEF SCIENTIFIC OFFICER | Option exercise 10b5-1 plan | 100.0K | 1.87 | 187.0K |
| 2026-07-15 | Sauvage Philippe Chief Financial Officer | Option exercise | 40.0K | 2.17 | 86.8K |
| 2026-07-15 | Sauvage Philippe Chief Financial Officer | Option exercise | 1 | 1.97 | 2 |
| 2026-06-23 | Markel Stacy CHIEF PEOPLE OFFICER | Open-market sale 10b5-1 plan | 125.0K | 6.03 | 753.2K |
| 2026-06-23 | Wentworth Kerry CHIEF REGULATORY OFFICER | Open-market sale 10b5-1 plan | 63.0K | 6.02 | 379.2K |
| 2026-06-23 | Sauvage Philippe Chief Financial Officer | Open-market sale 10b5-1 plan | 47.7K | 6.01 | 286.4K |
| 2026-06-23 | Wentworth Kerry CHIEF REGULATORY OFFICER | Option exercise 10b5-1 plan | 63.0K | 2.93 | 184.6K |
| 2026-06-23 | Markel Stacy CHIEF PEOPLE OFFICER | Option exercise 10b5-1 plan | 90.4K | 1.87 | 169.0K |
| 2026-06-23 | Sauvage Philippe Chief Financial Officer | Option exercise 10b5-1 plan | 47.7K | 2.17 | 103.4K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| FMR LLC | 223.0M | 52.0M |
| Decheng Capital LLC | 111.3M | 26.0M |
| BlackRock, Inc. | 107.7M | 25.1M |
| VANGUARD CAPITAL MANAGEMENT LLC | 49.9M | 11.6M |
| Omega Fund Management, LLC | 34.7M | 8.1M |
| Laurion Capital Management LP | 33.6M | 7.8M |
| STATE STREET CORP | 29.1M | 6.8M |
| GEODE CAPITAL MANAGEMENT, LLC | 25.2M | 5.9M |
| BANK OF AMERICA CORP /DE/ | 13.8M | 3.2M |
| Redmile Group, LLC | 13.5M | 3.2M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 144 | 2026-08-19 | — | on EDGAR ↗ |
| 8-K | 2026-08-06 | 2026-08-06 | on EDGAR ↗ |
| 10-Q | 2026-08-06 | 2026-06-30 | on EDGAR ↗ |
| 4 | 2026-07-17 | 2026-07-15 | on EDGAR ↗ |
| 8-K | 2026-07-06 | 2026-06-30 | on EDGAR ↗ |
| 8-K | 2026-06-30 | 2026-06-24 | on EDGAR ↗ |
| 424B5 | 2026-06-29 | — | on EDGAR ↗ |
| 305B2 | 2026-06-29 | — | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Why is Nuvation Bio stock rallying today? · 2026-08-21
- Nuvation Bio stock rises after Cantor starts at Overweight · 2026-08-21
- Nuvation Bio rises as Cantor initiates at overweight · 2026-08-21
- This Nvidia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday · 2026-08-21 · benzinga
- Nuvation Bio Inc. (NUVB) filed form 144 · 2026-08-19 · SEC EDGAR
- Nuvation Bio (NUVB) Q2 2026 Earnings Call Transcript · 2026-08-13
Ask the AI about NUVB
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →